Pontifax Management 4 G.P. (2015) Ltd. is 10% Owner at Eloxx Pharmaceuticals, Inc. (ELOX). They have made 4 open-market trades across 2 companies since 2018, most recently 2025-09-12.
4 open-market purchases totalling $15.5M since 2018, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.